The Inhibitors of the EPOR/JAK2/STAT3 Pathway Reversed the Suppressing Effect of EPO on the NLRP3 Inflammasome in LPS-Induced Acute Lung Injury. The gene discussed is JAK2; the disease is acute lung injury.